146 related articles for article (PubMed ID: 7496617)
1. Advances in atherosclerosis.
Spence JD
Baillieres Clin Neurol; 1995 Aug; 4(2):191-205. PubMed ID: 7496617
[TBL] [Abstract][Full Text] [Related]
2. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
Tschudi MR; Noll G; Lüscher TP
Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
[TBL] [Abstract][Full Text] [Related]
3. Allograft vasculopathy versus atherosclerosis.
Rahmani M; Cruz RP; Granville DJ; McManus BM
Circ Res; 2006 Oct; 99(8):801-15. PubMed ID: 17038650
[TBL] [Abstract][Full Text] [Related]
4. [Risk factors for arteriosclerosis].
Henzen C
Praxis (Bern 1994); 2001 Jan; 90(4):91-5. PubMed ID: 11213573
[TBL] [Abstract][Full Text] [Related]
5. Oxidative stress, antioxidant vitamins, and atherosclerosis. From basic research to clinical practice.
Antoniades C; Tousoulis D; Tentolouris C; Toutouzas P; Stefanadis C
Herz; 2003 Nov; 28(7):628-38. PubMed ID: 14689123
[TBL] [Abstract][Full Text] [Related]
6. Role of oxidative modifications in atherosclerosis.
Stocker R; Keaney JF
Physiol Rev; 2004 Oct; 84(4):1381-478. PubMed ID: 15383655
[TBL] [Abstract][Full Text] [Related]
7. [New information on the pathophysiology of atherosclerosis].
Reiner Z; Tedeschi-Reiner E
Lijec Vjesn; 2001; 123(1-2):26-31. PubMed ID: 11379194
[TBL] [Abstract][Full Text] [Related]
8. Effects of oxidized low-density lipoprotein on vascular contraction and relaxation: clinical and pharmacological implications in atherosclerosis.
Cox DA; Cohen ML
Pharmacol Rev; 1996 Mar; 48(1):3-19. PubMed ID: 8685247
[TBL] [Abstract][Full Text] [Related]
9. [The role of LDL in the origin and progression of atherosclerosis: pathobiological concepts on the origin and development of atherosclerotic lesions and the role of the endothelium].
De Caterina R; Lenzi S
G Ital Cardiol; 1998 Feb; 28(2):158-67. PubMed ID: 9534057
[TBL] [Abstract][Full Text] [Related]
10. Risk factors and their role in the diseases of the arterial wall.
Patel ST; Kent KC
Semin Vasc Surg; 1998 Sep; 11(3):156-68. PubMed ID: 9763116
[TBL] [Abstract][Full Text] [Related]
11. The pathophysiology of atherosclerosis.
Mitchell ME; Sidawy AN
Semin Vasc Surg; 1998 Sep; 11(3):134-41. PubMed ID: 9763113
[TBL] [Abstract][Full Text] [Related]
12. Pathogenesis of atherosclerosis.
Segrest JP; Anantharamaiah GM
Curr Opin Cardiol; 1994 Jul; 9(4):404-10. PubMed ID: 7919584
[TBL] [Abstract][Full Text] [Related]
13. Insulin resistance and endothelial dysfunction: the road map to cardiovascular diseases.
Cersosimo E; DeFronzo RA
Diabetes Metab Res Rev; 2006; 22(6):423-36. PubMed ID: 16506274
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
Kowalski M
J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
[TBL] [Abstract][Full Text] [Related]
15. [Action of natural estrogens on the vessel wall: molecular mechanisms and clinical implications].
Lüscher TF; Barton M; Wight E; Espinosa E; Yang Z
Schweiz Med Wochenschr; 1996 Oct; 126(41):1748-55. PubMed ID: 8966507
[TBL] [Abstract][Full Text] [Related]
16. Identifying the vulnerable patient with rupture-prone plaque.
Weintraub HS
Am J Cardiol; 2008 Jun; 101(12A):3F-10F. PubMed ID: 18549869
[TBL] [Abstract][Full Text] [Related]
17. The enigma of the endothelium.
Mathavan A; Shankar KJ; Misra KP
J Assoc Physicians India; 1999 Oct; 47(10):998-1002. PubMed ID: 10778696
[TBL] [Abstract][Full Text] [Related]
18. A novel apoA-I mutation (L178P) leads to endothelial dysfunction, increased arterial wall thickness, and premature coronary artery disease.
Hovingh GK; Brownlie A; Bisoendial RJ; Dube MP; Levels JH; Petersen W; Dullaart RP; Stroes ES; Zwinderman AH; de Groot E; Hayden MR; Kuivenhoven JA; Kastelein JJ
J Am Coll Cardiol; 2004 Oct; 44(7):1429-35. PubMed ID: 15464323
[TBL] [Abstract][Full Text] [Related]
19. Regression of atherosclerosis: which components regress and what influences their reversal.
Kramsch DM; Blankenhorn DH
Wien Klin Wochenschr; 1992; 104(1):2-9. PubMed ID: 1546480
[TBL] [Abstract][Full Text] [Related]
20. [Endothelial function in high risk cardiovascular patients].
Káli A; Jánosi A
Orv Hetil; 2006 Jan; 147(3):99-106. PubMed ID: 16515028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
